Bookmark list

Evotec Completes Acquisition of Kinaxo Biotechnologies GmbH

21-Apr-2011 - Germany

Evotec AG announced that it has completed the acquisition of Kinaxo Biotechnologies GmbH, a privately held drug discovery alliance company supporting the development of targeted drugs. As a result of the transaction, first announced on February 9, 2011, Kinaxo has become a wholly-owned subsidiary of Evotec. It is intended to grow and fully integrate the Kinaxo site in Munich, as Evotec Munich.

With the acquisition of Kinaxo, Evotec is expanding its drug discovery platform with cutting-edge technologies. Furthermore, Evotec adds proprietary technologies for drug response prediction as well as drug efficacy and safety assessment, especially in the key indication area oncology. Kinaxo's capabilities comprise a unique combination of innovative technologies improving drug discovery and development across the entire pharma value chain. These skills strengthen Evotec's position as the quality leader in drug discovery. The synergies are expected to result in a much broader customer reach through integration of the former Kinaxo service business into Evotec's performance based drug discovery alliances.

With the completion of the acquisition the sellers of the shares in Kinaxo Biotechnologies GmbH transferred 100% of their shares to Evotec AG. Therewith, all Closing conditions have been successfully fulfilled. Evotec AG issues 2.597.400 shares from its authorized capital as part consideration for the transaction. All Evotec shares issued are subject to certain lock-up provisions. Following the registration of these shares at the trade register, Evotec's issued share capital will be €118.193.132.

https://www.bionity.com/en/news/132036/evotec-completes-acquisition-of-kinaxo-biotechnologies-gmbh.html

Other news from the department business & finance

Good overall result and revenue growth for the ZEISS Group

"The ZEISS Group's broad portfolio ensures a pleasingly robust overall performance in a strained environment"

Get the life science industry in your inbox

Evotec Completes Acquisition of Kinaxo Biotechnologies GmbH

Other news from the department business & finance

Good overall result and revenue growth for the ZEISS Group

Merck to Acquire HUB Organoids Holding B.V.

Start-up EBViously founded

For better leukemia therapies: spin-off Cimeio partners with pharmaceutical company Kyowa Kirin

Lindis Blood Care announces successful financing for its tumour-cell-removal medical device

AQEMIA hits $100 million funding milestone

Concept Life Sciences and Accelero Biostructures partner to advance X-ray crystallography in early drug discovery

Orikine Bio secures €800k in innovation research funding to advance groundbreaking autoimmune disease therapy

Abselion raises £6.6 million led by M Ventures to bring disruptive at-line protein analyser to market

Refoxy Pharmaceuticals raises €9.1 million to progress its novel FOXO3 therapeutics for Idiopathic Pulmonary Fibrosis

miDiagnostics secures €30 million Series D funding round led by Thermo Fisher Scientific

Capitainer participates in global AI project for advanced lung diagnostics

Eppendorf SE and DataHow AG announce strategic collaboration to advance bioprocess data management

IDEAward for researchers’ start-up ideas

Start-up aims to bring AI-powered protein engineering to every lab

Roche acquires Poseida Therapeutics

Körber acquires Bähren Pharma-Packaging

Bayer further expands global incubator network with Bayer Co.Lab Berlin and welcomes MyoPax as first resident

QIAGEN Strengthens QIAstat-Dx With New Barcelona Site

Belgian start-up BIO INX and Carl ROTH partner to expand access to 3D bioprinting solutions

Get the life science industry in your inbox

Most read news

Microbe of the Year 2023: Bacillus subtilis – for health and technology

A new era of allergy treatment

CRISPR-Cas technology: ETH researchers have uncovered a serious side effect

‘Love hormone’ instead of opioids

Designing large new proteins with AI

Delivering medicines with microscopic flowers

Brain tumour cells rapidly integrate into brain-wide neuronal circuits

A stronghold in the fight against viruses - new bacterial immune system decoded

Concept Life Sciences and Accelero Biostructures partner to advance X-ray crystallography in early drug discovery

Cancer research: Small change with a big impact

From chip shop to pit stop

Abselion raises £6.6 million led by M Ventures to bring disruptive at-line protein analyser to market

More news from our other portals

Recycling batteries with citric acid

The science behind Magnum Bon Bon bite-sized ice creams

MIT gel changes color on demand

Plastic fantastic: Green, strong and edible

Food labeling in the EU is often misleading

Chemical analyses faster and more precise than ever before

Breakthrough in zinc-based rechargeable batteries: A safer, sustainable alternative

Beer like the Romans

Surfaces and Interfaces: Innovative techniques allow researchers to study interfaces with great precision

New method for new materials

Risk assessment: Essential ingredient for greater food safety

Smarter sensor sniffs out target gases

Researchers develop a new material that removes a dangerous “forever chemical,” from drinking water

Can AI improve plant-based meats?

Portable kit can recover traces of chemical evidence

Renewable Carbon Feedstocks: Building a Net-Zero Chemical Industry in 2050

Young people most stressed about spending family time this Christmas

Fresh iron from old mining sludge

Robots work in the bakery

Advanced Automation Technologies agrees to acquire GERSTEL

Why coffee needs an extra shot of Taylor Swift

Breakthrough: Previously unknown compound in chloraminated drinking water identified

Airy, delicious pastries with food foam made from peas

Liquid water molecules are inherently asymmetric

Color-Changing Test for Rapid Salmonella Detection

So close that even molecules turn red...

So close that even
molecules turn red...